Skip Navigation

Rheumatology 2008 47(4):559; doi:10.1093/rheumatology/ken036
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Peng, S. L.
Right arrow Articles by Gubbels Bupp, M. R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Peng, S. L.
Right arrow Articles by Gubbels Bupp, M. R.
Related Collections
Right arrow Experimental Arthritis
Right arrow Immunogenetics
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Comment on: The candidate lupus susceptibility gene Ifi202a is largely dispensable for B-cell function: reply

S. L. Peng and M. R. Gubbels Bupp

Roche Palo Alto, LLC – Inflammation, Autoimmunity and Transplantation Research, 3431 Hillview Ave Mailstop R7-101 Palo Alto, CA 94304, USA

Correspondence to: S. L. Peng, Roche Palo Alto, LLC – Inflammation, Autoimmunity and Transplantation Research, 3431 Hillview Ave Mailstop R7-101 Palo Alto, CA 94304, USA. E-mail: stanford.peng@roche.com

The first 10% of the full text of this article appears below.

SIR, Dr Choubey describes a number of known issues regarding the Ifi200 family, but overall, seems primarily to focus upon the likelihood that . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?